CINCINNATI--(BUSINESS WIRE)--Jan. 15, 2003--Meridian Bioscience,
Inc., (Nasdaq:VIVO) today announced that it has received from the U.S.
Patent and Trademark Office the official Notice of Allowance for a
patent entitled "Biological Sampling and Storage Container Utilizing a
Desiccant". The patent relates to a device for the sampling and
storing of specific biological samples used in medical testing. This
allowance compliments a patent that was granted earlier (Patent No.
6,299,842) and strengthens Meridian's position with respect to
transporting samples under desiccated (dried) conditions.
Lab tests that are performed on samples of body tissue (blood,
urine, feces, etc.) have become indispensable tools in aiding doctors
in diagnosing illness. Testing procedures that use samples collected
by non-invasive procedures, such as urine and feces, have become
increasingly critical for providing physicians with accurate results
that enable better patient management. These Meridian patents describe
a novel device that can be used for easily collecting and storing
samples, particularly feces, which need to be maintained in a
relatively dry atmosphere. This dry atmosphere stabilizes the
biologicals so that testing can occur at a later date. This invention
is simple enough to be used at home, allowing the patient to mail the
device directly to the lab for further processing and testing.
John A. Kraeutler, President and Chief Operating Officer, said,
"Meridian Bioscience has been, and continues to be a leader in
specimen transport and processing, and in developing innovative
diagnostic technologies for use in evaluating those specimens. These
two patents demonstrate Meridian's continued commitment to innovation
of easy to use products for its customers."
Meridian is a fully integrated life science company that
manufactures, markets and distributes a broad range of innovative
diagnostic test kits, purified reagents and related products and
offers biopharmaceutical enabling technologies. Utilizing a variety of
methods, these products provide accuracy, simplicity, and speed in the
early diagnosis and treatment of common medical conditions, such as
gastrointestinal, viral, urinary, and respiratory infections. All
Meridian products are used outside of the human body and require
little or no special equipment. The Company's products are designed to
enhance patient well-being while reducing the total outcome costs of
healthcare. Meridian has strong market positions in the areas of
gastrointestinal and upper respiratory infections, serology,
parasitology and fungal disease diagnosis. In addition, Meridian is a
supplier of rare reagents and specialty biologicals. The Company
markets its products to hospitals, reference laboratories, research
centers, veterinary testing centers and physician offices in more than
60 countries around the world. The Company's shares are traded through
Nasdaq's National Market, symbol VIVO. Meridian's website address is
Meridian Bioscience, Inc.
John A. Kraeutler, 513/271-3700